Nirsevimab Shows Strong Real-World Protection Against Severe RSV in Infants: Lancet Dr. Kamal Kant Kohli7 May 2025 9:15 PM ISTA meta-analysis indicates that the monoclonal antibody nirsevimab offers significant real-world protection against severe respiratory syncytial virus...
Timing of RSV Immunization Matters for Infant Protection suggests study Dr. Kamal Kant Kohli5 May 2025 8:30 PM ISTThe seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring its effectiveness,...
Nirsevimab highly effective against severe RSV disease in infants: JAMA Study Jacinthlyn Sylvia18 March 2025 6:00 AM ISTA new study published in the Journal of American Medical Association showed that nirsevimab offers protection against a variety of respiratory...
Sanofi Healthcare India gets CDSCO Panel nod to study Nirsevimab Dr. Divya Colin22 Jan 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug...
Merck application for RSV treatment Clesrovimab for infants accepted by USFDA Ruchika Sharma19 Dec 2024 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted...
Medical Bulletin 13/ November/ 2024 Dr. Bhumika Maikhuri13 Nov 2024 3:00 PM ISTHere are the top medical news for the day:Can Heart Medicine Lead to Depression?All patients who have had a heart attack are typically treated using...
Researchers Highlight the Best Time for RSV Vaccine During Pregnancy Dr. Bhumika Maikhuri13 Nov 2024 8:30 AM ISTCurrent guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-which typically causes mild, cold-like...
Approximately 80 Percent Protection May be Provided by RSV Vaccine Against Severe Disease and Death: Study Suggests Dr. Bhumika Maikhuri21 Oct 2024 8:15 AM ISTA multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the respiratory syncytial virus...
Hospitalized patients with RSV infections are at higher risk of mortality, finds study Jacinthlyn Sylvia21 Oct 2024 8:00 AM ISTA new study published in the journal of Open Forum Infectious Diseases showed that older adults hospitalized with respiratory syncytial virus (RSV)...
Merck's RSV antibody Clesrovimab for infants shows 60.4% effectiveness in mid-to-late stage clinical trial MD Bureau19 Oct 2024 12:15 PM ISTThe drug clesrovimab also helped reduce RSV associated hospitalizations by 84.2% compared to placebo, Merck said.
Medical Bulletin 15/ October/ 2024 Dr. Bhumika Maikhuri15 Oct 2024 3:00 PM ISTHere are the top medical news for the day:1 in 4 Adults Suspect They Have Undiagnosed ADHDA new national survey of 1,000 American adults commissioned...
Study Identifies Signs Tied to More Severe Cases of RSV Dr. Bhumika Maikhuri15 Oct 2024 8:15 AM ISTRespiratory syncytial virus (RSV) is the leading cause of hospitalization in young children due to respiratory complications such as bronchiolitis and...
